A half-century of anabolic steroids in sport

Steroids

Volumn 74, Issue 3, 2009, Pages 285-287

  Bowers, Larry D ^a   Clark, Richard V ^b   Shackleton, Cedric H L ^c  

^a United States Anti Doping Agency   (United States)

^b GLAXOSMITHKLINE   (United States)

^c CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; ANDROGEN; ANDROSTERONE DERIVATIVE; CLOSTEBOL ACETATE; CONTRACEPTIVE AGENT; EPITESTOSTERONE; ESTROGEN; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; METANDIENONE; METHYLTESTOSTERONE; NANDROLONE; NORBOLETONE; NORETHISTERONE; TESTOSTERONE; TESTOSTERONE ENANTATE; TETRAHYDROGESTRINONE;

ATHLETIC PERFORMANCE; BODY WEIGHT; CAPILLARY GAS CHROMATOGRAPHY; DIET SUPPLEMENTATION; DOPING; DOSE RESPONSE; DRUG ABUSE; DRUG DEPENDENCE; DRUG EFFECT; DRUG WITHDRAWAL; EDITORIAL; ERYTHROCYTOSIS; ESTROGEN ACTIVITY; FLUID RETENTION; FOOTBALL; HEALTH EDUCATION; HEART DISEASE; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HORMONE SUBSTITUTION; HORSE; HUMAN; LIPID BLOOD LEVEL; LIQUID CHROMATOGRAPHY; LUNG EDEMA; MASS SPECTROMETRY; MOOD DISORDER; MUSCLE MASS; MUSCLE STRENGTH; RADIOIMMUNOASSAY; SECOND TRIMESTER PREGNANCY; SIDE EFFECT; STEROID METABOLISM; SUICIDAL IDEATION; SUICIDE; TANDEM MASS SPECTROMETRY; THIRD TRIMESTER PREGNANCY; TREATMENT DURATION; VIOLENCE; WEIGHT LIFTING;

ANABOLIC AGENTS; DOPING IN SPORTS; STEROIDS; SUBSTANCE ABUSE DETECTION;

EID: 61349154147     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2009.01.007     Document Type: Editorial

References (39)

1. Wade N. Anabolic steroids: doctors denounce them, but athletes aren't listening. Science 176 (1972) 1399-1403
2. Berendonk B. Doping. Von der Forschung zum Betrug. Reinbeck bei Hamburg: Rowohlt Taschedbuchverlag; 1992. 448 p.
3. Franke W.W., and Berendonk B. Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government. Clin Chem 43 (1997) 1262-1279
4. Johnson L.C., and O'Shea J.P. Anabolic steroid: effect on strength development. Science 164 (1969) 957-959
5. Todd T. The steroid predicament. Sports Illustrated 1983; August 1.
6. Bhasin S., Storer T.W., Berman N., Callegari C., Clevenger B., Phillips J., et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med 335 (1996) 1-7
7. Shackleton C. Steroid analysis and doping control 1960-1980: scientific developments and personal anecdotes. Steroids 2009, this issue.
8. Masse R., Ayotte C., et al. Studies on anabolic steroids. I. Integrated methodological approach to the gas chromatographic-mass spectrometric analysis of anabolic steroid metabolites in urine. J Chromatogr 489 (1989) 23-50
9. Schänzer W., and Donike M. Metabolism of anabolic steroids in man: synthesis and use of reference substances for identification of anabolic steroid metabolites. Anal Chim Acta 275 (1993) 23-48
10. Schänzer W. Metabolism of anabolic androgenic steroids. Clin Chem 42 (1996) 1001-1020
11. Thevis M, Guddat S, Schänzer W. Doping control analysis of trenbolone and related compounds using liquid chromatography tandem mass spectrometry. Steroids 2009, this issue.
12. Donike M, Bärwald K-R, et al. Nachweis von exogenem testesteron. Sport: Leistung und Gesundheit. H. Heck, H. Hollman, H. Liesen and R. Rost. Cologne, Deutscher Ärtze Verlag, 1983, 293-8.
13. Jakobsson J., Ekstrom L., et al. Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism. J Clin Endocrinol Metab 91 (2006) 687-693
14. Sottas P.E., Baume N., Saudan C., Schweizer C., Kamber M., and Saugy M. Bayesian detection of abnormal values in longitudinal biomarkers with an application to T/E ratio. Biostatistics 8 (2007) 285-296
15. Jacobsson-Shultze J, Lundmark J, Garle M, Ekström L, Sottas P-E, Rane A. Substantial advantage of a combined Bayesian and genotyping approach in testosterone doping tests. Steroids 2009, this issue.
16. Reznik Y., Herrou M., Dehennin L., Lemaire M., and Leymarie P. Rising plasma levels of 19-nortestosterone throughout pregnancy: determination by radioimmunoassay and validation by gas chromatography-mass spectrometry. J Clin Endo Metab 64 (1987) 1086-1088
17. Hebestreit M., Flenker U., Fusshöller G., Geyer H., Güntner U., Mareck U., et al. Determination of the origin of urinary norandrosterone traces by gas chromatography combustion isotope ratio mass spectrometry. Analyst 131 (2006) 1021-1026
18. Walker CJ, Cowan DA, James VHT, Lau JCY, Kicman AT. Doping in Sport, Part 1: Excretion of 19-norandrosterone by healthy women, including those using contraceptives containing norethisterone. Steroids 2009, this issue.
19. Catlin D.H., Ahrens B.D., and Kucherova Y. Detection of norbolethone, an anabolic steroid never marketed, in athletes' urine. Rapid Commun Mass Spectrom 16 (2002) 1273-1275
20. Catlin D.H., Sekera M.H., Ahrens B.D., Starcevic B., Chang Y.C., and Hatton C.K. Tetrahydrogestrinone: discovery, synthesis, and detection in urine. Rapid Commun Mass Spectrom 18 (2004) 1245-1249
21. Sekera M.H., Ahrens B.D., Chang Y.C., Starcevic B., Georgakopoulos C., and Catlin D.H. Another designer steroid: discovery, synthesis, and detection of 'madol' in urine. Rapid Commun Mass Spectrom 19 (2005) 781-784
22. Parr M.K., Gütschow M., Daniels J., Opfermann G., Thevis M., and Schänzer W. Identification of steroid isoxazole isomers marketed as designer supplements. Steroids 74 (2009) 322-328
23. Bagatelle C.J., and Bremner W.J. Androgens in men: uses and abuses. N Engl J Med 334 (1996) 707-714
24. Hartgens F., and Kuipers H. Effects of androgenic-anabolic steroids in Athletes. Sports Med 34 (2004) 512-554
25. Clark R.V. Anabolic androgenic steroids: historical background, physiology, typical use and side effects. In: Fourcroy J.L. (Ed). Pharmacology, Doping and Sports (2008), Routledge, Oxon, England 23-35
26. Bhasin S., Woodhouse L., Casaburi R., Singh A.B., Bhasin D., Berman N., et al. Testosterone dose-response relationships in healthy young men. Am J Physiol 281 (2001) E1172-E1181
27. Bhasin S., Woodhouse L., Casaburi R., Singh A.B., Mac R.P., Lee M., et al. Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab 90 (2005) 678-688
28. Perry P.J., Lund B.C., Deninger M.J., Kutscher E.C., and Schneider J. Anabolic steroid use in weightlifters and bodybuilders-an internet survey of drug utilization. Clin J Sport Med 15 (2005) 326-330
29. Ishak K.G., and Zimmerman H.J. Hepatotoxic effects of the anabolic androgenic steroids. Semin Liver Dis 7 (1987) 230-236
30. Søe K.L., Søe M., and Gluud C. Liver pathology associated with the use of anabolic-androgenic steroids. Liver 12 (1992) 73-79
31. Socas L., Zumbado M., Pérez-Luzardo O., Ramos A., Pérez C., Hernández J.R., et al. Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report on two cases and a review of the literature. Br J Sports Med 39 (2005) e27
32. Nottin S., Nguyen L.D., Terbah M., and Obert P. Cardiovascular effects of androgenic anabolic steroids in male bodybuilders determined by tissue Doppler imaging. Am J Cardiol 97 (2006) 912-915
33. Krieg A., Scharhag J., Albers T., Kindermann W., and Urhausen A. Cardiac tissue Doppler imaging in sports medicine. Sports Med 37 (2007) 15-30
34. Fineschi V., Baroldi G., Monciotti F., Paglicci Reattelli L., and Turillazzi E. Anabolic steroid abuse and cardiac sudden death: a pathologic study. Arch Pathol Lab Med 125 (2001) 253-255
35. Nieminen M.S., Rämö M.P., Viitasalo M., Heikkilä P., Karjalainen J., Mäntysaari M., et al. Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters. Eur Heart J 17 (1996) 1576-1583
36. Glazer G. Atherogenic effects of anabolic steroids on serum lipid levels. Arch Internal Med 151 (1991) 1925-1933
37. Pope H.J., and Katz D.L. Psychiatric and medical effects of anabolic-androgenic steroid use. Arch Gen Psychiatry 51 (1994) 375-382
38. Pope Jr. H.G., Kouri E.M., and Hudson J.I. Effects of supraphysiological doses of testosterone on mood and aggression in normal men: a randomized controlled trial. Arch Gen Psychiatry 57 (2000) 133-140
39. Thiblin I., Lindquist O., and Rajs J. Causes and manner of death among users of anabolic androgenic steroids. J Forensic Sci 45 (2000) 16-23